Super Bone & Cardio CMD-K2
Natural health product licensed in Canada
- Other names
- GNN Signature® Super Bone & Cardio CMD-K2, Garlian® Super Super Bone & Cardio CMD-K2, Golden Beaver® Super Bone & Cardio CMD-K2, Sunnycreek® Super Bone & Cardio CMD-K2
- Licence holder
- Garlian Global Inc.
- NPN or DIN-HM
- 80112931
- Status
- Active licence
- Licence date
- 16 September 2021
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Magnésium: up to 350 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 350 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Succinate de calcium | 350 mg | 700,000 µg |
| Calcium Source : Fumarate de calcium | 350 mg | 700,000 µg |
| Calcium Source : Citrate de calcium | 350 mg | 700,000 µg |
| Calcium Source : Malate de calcium | 350 mg | 700,000 µg |
| Calcium Source : Carbonate de calcium | 350 mg | 700,000 µg |
| Magnésium Source : Citrate de magnésium | 175 mg | 350,000 µg |
| Magnésium Source : Succinate de magnésium | 175 mg | 350,000 µg |
| Magnésium Source : Oxyde de magnésium | 175 mg | 350,000 µg |
| Magnésium Source : Fumarate de magnésium | 175 mg | 350,000 µg |
| Magnésium Source : Malate de magnésium | 175 mg | 350,000 µg |
| Vitamine D Source : Cholécalciférol | 12.5 microgram | 25 µg |
| Vitamine D Source : Cholécalciférol | 500 UI | 25 µg |
| Vitamine K2 Source : Ménaquinone 7 | 60 microgram | 120 µg |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 30 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Cellulose microcristalline, Gelatin
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). As part of a healthy diet (when taken with Vitamin D) may help prevent bone loss/osteoporosis. Calcium intake, when combined with sufficient Vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps (to) maintain/support immune function. Helps in the absorption (and use) of calcium and phosphorus. Helps in the development and maintenance of bones and teeth. Helps in the maintenance of bones. Helps to build strong bones and teeth. Helps to maintain proper muscle function, including the heart muscle. (Provides) An antioxidant. Helps to maintain and/or support cardiovascular health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80112931
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.